Showing results (651-660 of 1,005) with videos related to
Sort By:
Pageof 101
Clinical Rheumatology|December 20, 2005
Severity of rheumatoid arthritis: the SEVERA studyRafic Baddoura, Souha Haddad, Hassane Awada, et al.BMC Cancer|May 28, 2026
Hematologic toxicity of immune checkpoint inhibitors: real-world burden and risk profiles from a five-year cohort from the Middle EastAli Awada, Ali Tarhini, Abbas Hammoud, et al.AJNR. American Journal of Neuroradiology|April 10, 2007
Acute Korsakoff-like amnestic syndrome resulting from left thalamic infarction following a right hippocampal hemorrhageR Rahme, R Moussa, A Awada, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|July 31, 2015
Tunable Keplerate Type-Cluster "Mo132 " Cavity with Dicarboxylate AnionsThanh-Loan Lai, Mouhamad Awada, Sébastien Floquet, et al.Endocrinology, Diabetes & Metabolism Case Reports|March 1, 2022
COVID-19 and Cushing's disease in a patient with ACTH-secreting pituitary carcinomaJ M K de Filette, Bastiaan Sol, Gil Awada, et al.Vaccines|November 13, 2020
Intratumoral Combinatorial Administration of CD1c (BDCA-1)<sup>+</sup> Myeloid Dendritic Cells Plus Ipilimumab and Avelumab in Combination with Intravenous Low-Dose Nivolumab in Patients with Advanced Solid Tumors: A Phase IB Clinical TrialJulia Katharina Schwarze, Gil Awada, Louise Cras, et al.European Journal of Endocrinology|October 28, 2020
Immune checkpoint inhibitor therapy for ACTH-secreting pituitary carcinoma: a new emerging treatment?Bastiaan Sol, Jeroen M K de Filette, Gil Awada, et al.Molecular Cancer Research : MCR|March 20, 2021
Dasatinib Stimulates Its Own Mechanism of Resistance by Activating a CRTC3/MITF/Bcl-2 Pathway in Melanoma with Mutant or Amplified c-KitMalak Sabbah, Mohammad Krayem, Ahmad Najem, et al.Medical Oncology (Northwood, London, England)|July 8, 2011
Maximising the duration of disease control in metastatic renal cell carcinoma with targeted agents: an expert agreementC Porta, G Tortora, C Linassier, et al.Current Pharmaceutical Design|August 17, 2018
Effects of Human Full-length Amelogenin and C-terminal Amelogenin Peptide on the Proliferation of Human Mesenchymal Stem Cells Derived from Adipose TissueKazuyo Ando, Ryo Kunimatsu, Tetsuya Awada, et al.Pageof 101